Oracea vs Soolantra

The Oracea label is explicit: it is indicated for the treatment of only inflammatory lesions, the papules and pustules, of rosacea in adult patients, and it states separately that it has not been evaluated for the erythematous, telangiectatic or ocular components of the condition. In plainer terms, the flushing, the visible vessels and the eye involvement are outside what was studied.

The Soolantra label is indicated for the treatment of inflammatory lesions of rosacea, with the same limit implied by the same wording.

This matters more than the difference between the two products. Someone whose main complaint is persistent facial redness is looking at two medicines that were approved for something else.

Oracea contains doxycycline, a tetracycline-class drug, at a dose its own label sets apart. The label states that this formulation has not been evaluated in the treatment or prevention of infections, and instructs that it not be used for treating bacterial infections, for antibacterial prophylaxis, or for reducing or eliminating the microorganisms associated with any bacterial disease.

It also warns that exceeding the recommended dosage may increase side effects, including the development of resistant microorganisms. Both statements are unusual to find in a label and both are worth reading before assuming that a tetracycline is being prescribed as an antibiotic.

The Soolantra label states that the mechanism of action of the cream in treating rosacea lesions is unknown. It lists no contraindications at all.

Oracea is contraindicated in people who have shown hypersensitivity to doxycycline or to other tetracyclines, which is the ordinary contraindication for its class.

Oracea is one capsule once daily in the morning on an empty stomach, at least an hour before or two hours after a meal. Soolantra is applied once daily as a pea-sized amount for each affected area of the face, spread thinly and kept away from the eyes and lips.

The reported adverse reactions follow the route. The Oracea list is systemic: nasopharyngitis, sinusitis, diarrhoea, raised blood pressure and an increase in a liver enzyme. The Soolantra list is local and reported at a low incidence: a burning sensation of the skin and skin irritation.

It does not say which one a person should use, and it does not rank them. The two were approved on separate trials that were not designed to compare them, and rosacea is a condition where what a person notices most may not be what either label covers.